Health Canada drug identification number

DIN 02508419 — HYOSCINE BUTYLBROMIDE INJECTION BP 20 MG

HYOSCINE BUTYLBROMIDE INJECTION BP is a solution of Hyoscine Butylbromide marketed by OMEGA LABORATORIES LIMITED. The full Hyoscine Butylbromide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02508419
Brand name
HYOSCINE BUTYLBROMIDE INJECTION BP
Active ingredient
Hyoscine Butylbromide
Strength
20 MG
Dosage form
SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Manufacturer
OMEGA LABORATORIES LIMITED
Health Canada status
MARKETED
Drug class
Antimuscarinic (antispasmodic) agent

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Hyoscine Butylbromide products

DINBrandStrengthFormManufacturerStatus
02512335 ACCEL-HYOSCINE 10 MG TABLET ACCEL PHARMA INC MARKETED
00363812 BUSCOPAN 10 MG TABLET SANOFI CONSUMER HEALTH INC MARKETED
00363839 BUSCOPAN 20 MG SOLUTION SANOFI CONSUMER HEALTH INC MARKETED
02229868 HYOSCINE BUTYLBROMIDE INJECTION 20 MG SOLUTION SANDOZ CANADA INCORPORATED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.